US Pharma MarketingTransforming neurodegenerative disease treatment
Cognition Therapeutics, led by CEO Lisa Ricciardi, is on a mission to change the course of neurodegenerative diseases. Discover how Cognition Therapeutics is redefining hope for Alzheimer’s and Dementia with Lewy bodies [JG1] with innovative, accessible therapies.
Discover how Cognition Therapeutics is redefining hope for Alzheimer’s and Dementia with Lewy bodies [JG1] with innovative, accessible therapies.
Source: FierceBiotech